Riassunto: Ncardia firma un accordo di licenza con il primo partner farmaceutico per il portafoglio di brevetti dedicati al disease modeling

View Full Size

Download

Full Size JPEG, 800x225, 79.9 KB
Small JPEG, 480x135, 42.2 KB
Preview JPEG, 144x41, 7.2 KB
Thumbnail JPEG, 120x34, 5.6 KB

Smart Multimedia Gallery

Ncardia is a leader in standardized, validated iPSC assays for safety, phenotypic screening and disease modeling. For scientists conducting cardiovascular and neural safety and efficacy projects, Ncardia is providing tools to facilitate accelerated development of drugs, while replacing animal studies and putting a "human" aspect back into drug discovery. (Graphic: Business Wire)